CSIMarket
 


National Research Corporation  (NRC)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

NRC's Revenue Growth by Quarter and Year

National Research's Revenue results by quarter and year




NRC Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 38.00 38.14 38.30
III Quarter September - 37.95 37.69 37.77
II Quarter June - 36.16 37.29 36.43
I Quarter March 35.31 36.47 38.44 35.46
FY   35.31 148.58 151.56 147.96



NRC Revenue first quarter 2024 Y/Y Growth Comment
National Research Corporation reported decrease in Revenue in the first quarter 2024 by -3.17% to $ 35.31 millions, from the same quarter in 2023.
The decrease in the first quarter 2024 National Research Corporation's Revenue compares unfavorably to the Company's average Revenue increase of 10.59%.

Looking into first quarter 2024 results within Medical Laboratories industry 10 other companies have achieved higher Revenue growth. While National Research Corporation' s Revenue decline of -3.17% ranks overall at the positon no. 1291 in the first quarter 2024.




NRC Revenue ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - -0.37 % -0.42 % 10.15 %
III Quarter September - 0.69 % -0.21 % 12.81 %
II Quarter June - -3.03 % 2.36 % 16.88 %
I Quarter March -3.17 % -5.12 % 8.4 % 4.73 %
FY   - -1.97 % 2.43 % 11.01 %

Financial Statements
National Research's first quarter 2024 Revenue $ 35.31 millions NRC's Income Statement
National Research's first quarter 2023 Revenue $ 36.47 millions Quarterly NRC's Income Statement
New: More NRC's historic Revenue Growth >>


NRC Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - 0.13 % 1.19 % 1.4 %
III Quarter September - 4.95 % 1.07 % 3.68 %
II Quarter June - -0.85 % -2.99 % 2.74 %
I Quarter March -7.07 % -4.38 % 0.37 % 1.98 %
FY (Year on Year)   - -1.97 % 2.43 % 11.01 %




Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #11
Healthcare Sector #198
Overall #1291

Revenue Y/Y Growth Statistics
High Average Low
118.25 % 10.59 % -2.19 %
(Sep 30 2017)   (Jun 30 2023)
Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #11
Healthcare Sector #198
Overall #1291
Revenue Y/Y Growth Statistics
High Average Low
118.25 % 10.59 % -2.19 %
(Sep 30 2017)   (Jun 30 2023)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

National Research's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
13.55 % 0.63 % -10.25 %
(Mar 31 2014)  


NRC's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 National Research Corporation reported drop in Revenue from the previous quarter by -7.07% to $ 35.31 millions, from $ 38.00 millions released in the previous quarter.

But that's not huge problem, as Revenue always seem to plunge in the I. Quarter.

Within Medical Laboratories industry 14 other companies have achieved higher Revenue quarter on quarter growth. While National Research's Revenue growth quarter on quarter, overall rank is 1478.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #15
Healthcare Sector #175
Overall #1478
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #15
Healthcare Sector #175
Overall #1478
Revenue Q/Q Growth Statistics
High Average Low
13.55 % 0.63 % -10.25 %
(Mar 31 2014)  


NRC's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 National Research Corporation reported drop in Revenue from the fourth quarter by -7.07% to $ 35.31 millions, from $ 38.00 millions declared in the previous quarter.

As we evaluate current slump in the quarter, we must assume, that commonly I. Quarter 2024 results appear to be sluggish relative to the fourth quarter, Nellie Svensson, an industry expert said.

Within Medical Laboratories industry 14 other companies have achieved higher Revenue quarter on quarter growth. While National Research's Revenue growth quarter on quarter, overall rank is 1478.


National Research's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
Cumulative Revenue 12 Months Ending $ 147.42 $ 148.58 $ 148.72 $ 148.47 $ 149.60
Y / Y Revenue Growth (TTM) -1.46 % -1.97 % -1.98 % -2.19 % -0.88 %
Year on Year Revenue Growth Overall Ranking # 1261 # 1681 # 1775 # 778 # 1110
Seqeuential Revenue Change (TTM) -0.78 % -0.1 % 0.17 % -0.76 % -1.3 %
Seq. Revenue Growth (TTM) Overall Ranking # 1291 # 1155 # 2221 # 1184 # 1734




Cumulative Revenue growth Comment
National Research showed decline, but improvement compare to trailing twelve month Revenue decrease in Dec 31 2023. If the fiscal year would end in Mar 31 2024, National Research's annual Revenue decline would be -1.46% year on year to $147 millions.

In the Healthcare sector 196 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1261, from total ranking in previous quarter at 1681.

Revenue TTM Q/Q Growth Statistics
High Average Low
118.25 %
10.59 %
-2.19 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 11
Healthcare Sector # 197
Overall # 1261

Revenue TTM Y/Y Growth Statistics
High Average Low
118.25 %
10.59 %
-2.19 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 11
Sector # 198
S&P 500 # 1291
Cumulative Revenue growth Comment
National Research showed decline, but improvement compare to trailing twelve month Revenue decrease in Dec 31 2023. If the fiscal year would end in Mar 31 2024, National Research's annual Revenue decline would be -1.46% year on year to $147 millions.

In the Healthcare sector 196 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1261, from total ranking in previous quarter at 1681.

Revenue TTM Q/Q Growth Statistics
High Average Low
118.25 %
10.59 %
-2.19 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 11
Healthcare Sector # 197
Overall # 1261

Revenue TTM Y/Y Growth Statistics
High Average Low
118.25 %
10.59 %
-2.19 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 11
Sector # 198
S&P 500 # 1291




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NRC's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for NRC's Competitors
Revenue Growth for National Research's Suppliers
Revenue Growth for NRC's Customers

You may also want to know
NRC's Annual Growth Rates NRC's Profitability Ratios NRC's Asset Turnover Ratio NRC's Dividend Growth
NRC's Roe NRC's Valuation Ratios NRC's Financial Strength Ratios NRC's Dividend Payout Ratio
NRC's Roa NRC's Inventory Turnover Ratio NRC's Growth Rates NRC's Dividend Comparisons



Companies with similar Revenue decline for the quarter ending Mar 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2024
Collegium Pharmaceutical inc -0.21%$ -0.215 millions
Mettler Toledo International Inc-0.30%$ -0.300 millions
3m Company-0.35%$ -0.349 millions
Icu Medical Inc-0.42%$ -0.423 millions
Lifeloc Technologies Inc -0.51%$ -0.513 millions
Regeneron Pharmaceuticals Inc -0.54%$ -0.541 millions
Envista Holdings Corporation-0.62%$ -0.622 millions
Vyne Therapeutics Inc -1.01%$ -1.010 millions
Ge Healthcare Technologies Inc -1.50%$ -1.502 millions
Baxter International Inc -1.56%$ -1.562 millions
Y mabs Therapeutics inc -1.58%$ -1.580 millions
Pacific Biosciences Of California Inc -1.59%$ -1.589 millions
Cartesian Therapeutics Inc -1.65%$ -1.650 millions
Viatris Inc -1.76%$ -1.762 millions
Ocuphire Pharma Inc -2.17%$ -2.173 millions
Vaso Corporation-2.51%$ -2.513 millions
Dentsply Sirona Inc -2.56%$ -2.556 millions
Alpha Pro Tech Ltd -2.78%$ -2.775 millions
Prestige Consumer Healthcare Inc -2.82%$ -2.817 millions
West Pharmaceutical Services Inc -2.99%$ -2.986 millions
Integra Lifesciences Holdings Corp-3.14%$ -3.144 millions
Accelerate Diagnostics Inc -3.17%$ -3.165 millions
National Research Corporation-3.18%$ -3.180 millions
Catheter Precision Inc -3.53%$ -3.529 millions
Elanco Animal Health Inc-4.14%$ -4.137 millions
Ptc Therapeutics inc -4.66%$ -4.657 millions
Foghorn Therapeutics Inc -4.88%$ -4.879 millions
Aclaris Therapeutics Inc -5.14%$ -5.142 millions
Avantor Inc -5.65%$ -5.645 millions
The Beauty Health Company-5.70%$ -5.699 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com